Most cited papers from Athersys (United States)

Athersys (United States)

What are the most cited papers from Athersys (United States)?

The most cited paper from Athersys (United States) is "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement" (Massimo Dominici, Katarina Le Blanc, Ingo Mueller et al., 2006), with 18,014 citations. Next come "Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement" (2,079) and "Formation of de novo centromeres and construction of first-generation human artificial microchromosomes" (656).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 47 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Massimo Dominici, Katarina Le Blanc, Ingo Mueller et al. · Cytotherapy	2006	18,014
2	Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement E.M. Horwitz, Katarina Le Blanc, Massimo Dominici et al. · Cytotherapy	2005	2,079
3	Formation of de novo centromeres and construction of first-generation human artificial microchromosomes John Harrington, Gil Van Bokkelen, Robert W. Mays et al. · Nature Genetics	Apr 1997	656
4	International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials Jacques Galipeau et al. · Cytotherapy Open access	23 Dec 2015	534
5	Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial David Charles Hess, Lawrence R. Wechsler, Wayne M. Clark et al. · The Lancet Neurology	17 Mar 2017	377
6	Identification of a Novel Extracellular Cation-sensing G-protein-coupled Receptor Min Pi, Pieter W. Faber, George Ekema et al. · Journal of Biological Chemistry Open access	Oct 2005	318
7	Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II Sean Isaac Savitz, Michael Chopp, Robert Deans et al. · Stroke Open access	27 Jan 2011	267
8	Bioenergetic and Functional Consequences of Bone Marrow–Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling Lepeng Zeng, Qingsong Hu, Xiaohong Wang et al. · Circulation	27 Mar 2007	262
9	Assessing the Safety of Stem Cell Therapeutics Christopher E. Goldring, Paul A. Duffy, Nissim Benvenisty et al. · Cell stem cell Open access	Jun 2011	257
10	GPRC6A Null Mice Exhibit Osteopenia, Feminization and Metabolic Syndrome Min Pi, Ling Chen, Minzhao Huang et al. · PLoS ONE Open access	2 Dec 2008	255
11	Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry Christopher A. Bravery, Jessica Carmen, Timothy C. Fong et al. · Cytotherapy	2013	204
12	Stem Cells as an Emerging Paradigm in Stroke 3 Sean Isaac Savitz et al. · Stroke Open access	25 Dec 2013	155
13	Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: Preserving the blood brain barrier via an interaction with splenocytes Peter A. Walker, Shinil K. Shah, Fernando Jiménez et al. · Experimental Neurology Open access	19 Jul 2010	147
14	Multipotent Adult Progenitor Cells Prevent Macrophage-Mediated Axonal Dieback and Promote Regrowth after Spinal Cord Injury Sarah A. Busch, Jason A. Hamilton, Kevin P. Horn et al. · Journal of Neuroscience Open access	19 Jan 2011	146
15	Soliciting Strategies for Developing Cell-Based Reference Materials to Advance Mesenchymal Stromal Cell Research and Clinical Translation Sowmya Viswanathan, Armand Keating, Robert Deans et al. · Stem Cells and Development Open access	14 Jan 2014	128
16	Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells Raf Donders, Jeroen F. J. Bogie, Stylianos Ravanidis et al. · Stem Cells and Development	21 Dec 2017	124
17	Intravenous Grafts Recapitulate the Neurorestoration Afforded by Intracerebrally Delivered Multipotent Adult Progenitor Cells in Neonatal Hypoxic-Ischemic Rats Takao Yasuhara, Koichi Hara, Mina Maki et al. · Journal of Cerebral Blood Flow & Metabolism Open access	2 Jul 2008	124
18	Adventitial Delivery of an Allogeneic Bone Marrow–Derived Adherent Stem Cell in Acute Myocardial Infarction Marc S. Penn, Stephen G. Ellis, Sanjay Gandhi et al. · Circulation Research Open access	4 Nov 2011	116
19	Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population Peter A. Walker, Supinder Singh Bedi, Shinil K. Shah et al. · Journal of Neuroinflammation Open access	28 Sep 2012	113
20	Emerging roles for multipotent, bone marrow–derived stromal cells in host defense Jeffery J. Auletta, Robert Deans, Amelia M. Bartholomew · Blood Open access	7 Jan 2012	104
21	The Prolactin-Releasing Peptide Receptor (GPR10) Regulates Body Weight Homeostasis in Mice Wei Gu, Brad J. Geddes, Cheng Zhang et al. · Journal of Molecular Neuroscience	2004	97
22	A Double-Blind Placebo-Controlled Clinical Evaluation of Multistem for the Treatment of Ischemic Stroke David Charles Hess, Cathy A. Sila, Anthony J. Furlan et al. · International Journal of Stroke	22 May 2013	94
23	Stem Cells as an Emerging Paradigm in Stroke 4 Johannes Boltze et al. · Stroke	17 Oct 2019	93
24	Behavioral and Histological Characterization of Intrahippocampal Grafts of Human Bone Marrow-Derived Multipotent Progenitor Cells in Neonatal Rats with Hypoxic-Ischemic Injury Takao Yasuhara, Noriyuki Matsukawa, Guolong Yu et al. · Cell Transplantation Open access	Mar 2006	90
25	Human Multipotent Adult Progenitor Cells Are Nonimmunogenic and Exert Potent Immunomodulatory Effects on Alloreactive T-Cell Responses Sandra A. Jacobs, Jef A. PINXTEREN, Valerie D. Roobrouck et al. · Cell Transplantation Open access	5 Apr 2013	90
26	Multipotent Adult Progenitor Cells Enhance Recovery After Stroke by Modulating the Immune Response from the Spleen Bing Yang, Jason A. Hamilton, Krystal S. Valenzuela et al. · Stem Cells Open access	6 Mar 2017	87
27	The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors L. Nathan Tumey, David C. Bom, Bayard R. Huck et al. · Bioorganic & Medicinal Chemistry Letters Open access	15 Dec 2004	85
28	Development of a surrogate angiogenic potency assay for clinical-grade stem cell production Nicholas Lehman, Rochelle Cutrone, Amy Raber et al. · Cytotherapy	9 Jul 2012	81
29	Identification of a human NF-κB-activating protein, TAB3 Ge Jin, Alison K. Klika, Michelle Callahan et al. · Proceedings of the National Academy of Sciences Open access	6 Feb 2004	81
30	Feeding response to ghrelin agonist and antagonist in lean and obese Zucker rats Bernard Beck, Sébastien Richy, Alain Stricker‐Krongrad · Life Sciences	6 Nov 2004	80
31	Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation Emily R. Thompson et al. · American Journal of Transplantation Open access	7 Jun 2020	78
32	Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting Marcella Franquesa et al. · Transplantation Open access	12 Jun 2013	73
33	Clinical-Grade Multipotent Adult Progenitor Cells Durably Control Pathogenic T Cell Responses in Human Models of Transplantation and Autoimmunity James L. Reading, Jennie H. M. Yang, Shereen Sabbah et al. · The Journal of Immunology	2 Apr 2013	72
34	Advancement of Mesenchymal Stem Cell Therapy in Solid Organ Transplantation (MISOT) Martin Johannes Hoogduijn et al. · Transplantation Open access	3 Jul 2010	71
35	Creation of genome-wide protein expression libraries using random activation of gene expression John Harrington et al. · Nature Biotechnology	May 2001	71
36	Application of MultiStem® Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease Bart L. T. Vaes, Wouter Van’t Hof, Robert Deans et al. · Frontiers in Immunology Open access	2012	71
37	Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group Marc Hendrik Dahlke et al. · Transplantation Open access	3 Sep 2009	71
38	Intravenous Multipotent Adult Progenitor Cell Therapy Attenuates Activated Microglial/Macrophage Response and Improves Spatial Learning After Traumatic Brain Injury Supinder Singh Bedi, Robert A. Hetz, Chelsea P. Thomas et al. · Stem Cells Translational Medicine Open access	4 Nov 2013	70
39	Global Characterization and Genomic Stability of Human MultiStem, A Multipotent Adult Progenitor Cell. Sherry Boozer, Nicholas Lehman, Uma Lakshmipathy et al. · PubMed	2009	69
40	Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial Richard Thomas Maziarz, Timothy Devos, Carlos R. Bachier et al. · Transplantation and Cellular Therapy Open access	30 Dec 2014	67
41	First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation Yorick Soeder, Martin Loss, Christian L. Johnson et al. · Stem Cells Translational Medicine Open access	3 Jun 2015	67
42	Molecular Imaging of the Paracrine Proangiogenic Effects of Progenitor Cell Therapy in Limb Ischemia Jae Choon Ryu, Brian P. Davidson, Aris Xie et al. · Circulation Open access	11 Jan 2013	66
43	Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells Peter W. Andrews, Joy A. Cavagnaro, Robert Deans et al. · Nature Biotechnology	Aug 2014	65
44	Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury Marc A. DePaul, Marc Palmer, Bradley T. Lang et al. · Scientific Reports Open access	19 Nov 2015	64
45	Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct Wouter Van’t Hof, Niladri Mal, Yan Hong Huang et al. · Cytotherapy	2007	64
46	Identification of Novel and Improved Antimitotic Agents Derived from Noscapine James T. Anderson, Anthony E. Ting, Sherry Boozer et al. · Journal of Medicinal Chemistry	13 Oct 2005	63
47	Concise Review: Guidance in Developing Commercializable Autologous/Patient-Specific Cell Therapy Manufacturing Shannon S. Eaker, Myriam A. Armant, Harvey J. Brandwein et al. · Stem Cells Translational Medicine Open access	7 Oct 2013	61
48	The Delivery of Multipotent Adult Progenitor Cells to Extended Criteria Human Donor Livers Using Normothermic Machine Perfusion Richard W. Laing, Samantha R. Stubblefield, Lorraine M. Wallace et al. · Frontiers in Immunology Open access	25 Jun 2020	60
49	Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation Alice Valentin-Torres, Carine Savarin, Joslyn Barnett et al. · Journal of Neuroinflammation Open access	24 Apr 2018	60
50	Human adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep Mauricio M. Rojas, Nayra Cárdenes, Ergin Koçyıldırım et al. · Stem Cell Research & Therapy Open access	26 Mar 2014	57

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.